182 related articles for article (PubMed ID: 23762367)
1. Time to treatment and patient outcomes among TB suspects screened by a single point-of-care xpert MTB/RIF at a primary care clinic in Johannesburg, South Africa.
Hanrahan CF; Selibas K; Deery CB; Dansey H; Clouse K; Bassett J; Scott L; Stevens W; Sanne I; Van Rie A
PLoS One; 2013; 8(6):e65421. PubMed ID: 23762367
[TBL] [Abstract][Full Text] [Related]
2. Impact of a novel molecular TB diagnostic system in patients at high risk of TB mortality in rural South Africa (Uchwepheshe): study protocol for a cluster randomised trial.
Lessells RJ; Cooke GS; McGrath N; Nicol MP; Newell ML; Godfrey-Faussett P
Trials; 2013 Jun; 14():170. PubMed ID: 23758662
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of gene xpert for routine diagnosis of HIV-associated tuberculosis in Nigeria: A prospective cohort study.
Akanbi MO; Achenbach C; Taiwo B; Idoko J; Ani A; Isa Y; Agbaji O; Ukoli C; Akande P; Maiga M; Murphy RL
BMC Pulm Med; 2017 May; 17(1):87. PubMed ID: 28558662
[TBL] [Abstract][Full Text] [Related]
4. Impact of Point-of-Care Xpert MTB/RIF on Tuberculosis Treatment Initiation. A Cluster-randomized Trial.
Lessells RJ; Cooke GS; McGrath N; Nicol MP; Newell ML; Godfrey-Faussett P
Am J Respir Crit Care Med; 2017 Oct; 196(7):901-910. PubMed ID: 28727491
[TBL] [Abstract][Full Text] [Related]
5. Accuracy of the Xpert MTB/RIF test for the diagnosis of pulmonary tuberculosis in children admitted to hospital in Cape Town, South Africa: a descriptive study.
Nicol MP; Workman L; Isaacs W; Munro J; Black F; Eley B; Boehme CC; Zemanay W; Zar HJ
Lancet Infect Dis; 2011 Nov; 11(11):819-24. PubMed ID: 21764384
[TBL] [Abstract][Full Text] [Related]
6. Population health impact and cost-effectiveness of tuberculosis diagnosis with Xpert MTB/RIF: a dynamic simulation and economic evaluation.
Menzies NA; Cohen T; Lin HH; Murray M; Salomon JA
PLoS Med; 2012; 9(11):e1001347. PubMed ID: 23185139
[TBL] [Abstract][Full Text] [Related]
7. Performance of the Abbott RealTi
Scott L; David A; Noble L; Nduna M; Da Silva P; Black A; Venter F; Stevens W
J Clin Microbiol; 2017 Aug; 55(8):2491-2501. PubMed ID: 28592547
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic delays and clinical decision making with centralized Xpert MTB/RIF testing in Durban, South Africa.
Cohen GM; Drain PK; Noubary F; Cloete C; Bassett IV
J Acquir Immune Defic Syndr; 2014 Nov; 67(3):e88-93. PubMed ID: 25314255
[TBL] [Abstract][Full Text] [Related]
9. A comparison of the Xpert(®) MTB/RIF and GenoType(®) MTBDRplus assays in Georgia.
Bablishvili N; Tukvadze N; Avaliani Z; Blumberg HM; Kempker RR
Int J Tuberc Lung Dis; 2015 Jun; 19(6):676-8. PubMed ID: 25946358
[TBL] [Abstract][Full Text] [Related]
10. Correlation of Xpert MTB/RIF with measures to assess Mycobacterium tuberculosis bacillary burden in high HIV burden areas of Southern Africa.
Beynon F; Theron G; Respeito D; Mambuque E; Saavedra B; Bulo H; Sanz S; Dheda K; Garcia-Basteiro AL
Sci Rep; 2018 Mar; 8(1):5201. PubMed ID: 29581435
[TBL] [Abstract][Full Text] [Related]
11. The cost-effectiveness of routine tuberculosis screening with Xpert MTB/RIF prior to initiation of antiretroviral therapy: a model-based analysis.
Andrews JR; Lawn SD; Rusu C; Wood R; Noubary F; Bender MA; Horsburgh CR; Losina E; Freedberg KA; Walensky RP
AIDS; 2012 May; 26(8):987-95. PubMed ID: 22333751
[TBL] [Abstract][Full Text] [Related]
12. Early Outcomes Of Decentralized Care for Rifampicin-Resistant Tuberculosis in Johannesburg, South Africa: An Observational Cohort Study.
Berhanu R; Schnippel K; Mohr E; Hirasen K; Evans D; Rosen S; Sanne I
PLoS One; 2016; 11(11):e0164974. PubMed ID: 27812140
[TBL] [Abstract][Full Text] [Related]
13. Treatment decisions and mortality in HIV-positive presumptive smear-negative TB in the Xpert™ MTB/RIF era: a cohort study.
Hermans SM; Babirye JA; Mbabazi O; Kakooza F; Colebunders R; Castelnuovo B; Sekaggya-Wiltshire C; Parkes-Ratanshi R; Manabe YC
BMC Infect Dis; 2017 Jun; 17(1):433. PubMed ID: 28622763
[TBL] [Abstract][Full Text] [Related]
14. Scaling up Xpert MTB/RIF technology: the costs of laboratory- vs. clinic-based roll-out in South Africa.
Schnippel K; Meyer-Rath G; Long L; MacLeod W; Sanne I; Stevens WS; Rosen S
Trop Med Int Health; 2012 Sep; 17(9):1142-51. PubMed ID: 22686606
[TBL] [Abstract][Full Text] [Related]
15. Bacterial Loads Measured by the Xpert MTB/RIF Assay as Markers of Culture Conversion and Bacteriological Cure in Pulmonary TB.
Shenai S; Ronacher K; Malherbe S; Stanley K; Kriel M; Winter J; Peppard T; Barry CE; Wang J; Dodd LE; Via LE; Barry CE; Walzl G; Alland D
PLoS One; 2016; 11(8):e0160062. PubMed ID: 27508390
[TBL] [Abstract][Full Text] [Related]
16. Effect of Antiretroviral Therapy on Treatment Outcomes in a Prospective Study of Extensively Drug-Resistant Tuberculosis (XDR-TB) HIV Coinfection Treatment in KwaZulu-Natal, South Africa.
Yuengling KA; Padayatchi N; Wolf A; Mathema B; Brown T; Horsburgh CR; OʼDonnell MR
J Acquir Immune Defic Syndr; 2018 Dec; 79(4):474-480. PubMed ID: 30212394
[TBL] [Abstract][Full Text] [Related]
17. Exhaled Mycobacterium tuberculosis output and detection of subclinical disease by face-mask sampling: prospective observational studies.
Williams CM; Abdulwhhab M; Birring SS; De Kock E; Garton NJ; Townsend E; Pareek M; Al-Taie A; Pan J; Ganatra R; Stoltz AC; Haldar P; Barer MR
Lancet Infect Dis; 2020 May; 20(5):607-617. PubMed ID: 32085847
[TBL] [Abstract][Full Text] [Related]
18. Improved Survival and Cure Rates With Concurrent Treatment for Multidrug-Resistant Tuberculosis-Human Immunodeficiency Virus Coinfection in South Africa.
Brust JCM; Shah NS; Mlisana K; Moodley P; Allana S; Campbell A; Johnson BA; Master I; Mthiyane T; Lachman S; Larkan LM; Ning Y; Malik A; Smith JP; Gandhi NR
Clin Infect Dis; 2018 Apr; 66(8):1246-1253. PubMed ID: 29293906
[TBL] [Abstract][Full Text] [Related]
19. Tuberculosis infection and disease in South African adolescents with perinatally acquired HIV on antiretroviral therapy: a cohort study.
Frigati LJ; Wilkinson KA; le Roux S; Brown K; Ruzive S; Githinji L; Petersen W; Belard S; Cotton MF; Myer L; Zar HJ
J Int AIDS Soc; 2021 Mar; 24(3):e25671. PubMed ID: 33719199
[TBL] [Abstract][Full Text] [Related]
20. Challenges in detection and treatment of multidrug resistant tuberculosis patients in Vietnam.
Hoang TT; Nguyen NV; Dinh SN; Nguyen HB; Cobelens F; Thwaites G; Nguyen HT; Nguyen AT; Wright P; Wertheim HF
BMC Public Health; 2015 Sep; 15():980. PubMed ID: 26415893
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
